Clinical Trial Update: Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for dexmedetomidine in treating symptoms of acute opioid withdrawal (Phase 1/2) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Withdrawal

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: BioXcel Therapeutics Inc | Conditions: Opioid Withdrawal | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-10-26